Use of Inhibitors of the Activity or Function of PI3K
申请人:NOVARTIS AG
公开号:US20150342951A1
公开(公告)日:2015-12-03
The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
BENZPYRAZOLE DERIVATIVES AS INHIBITORS OF PI3 KINASES
申请人:Baldwin Ian Robert
公开号:US20120245171A1
公开(公告)日:2012-09-27
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I):
and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
BENZPYRAZOLE DERIVATIVES AS INHIBITORS OF P13 KINASES
申请人:Glaxo Group Limited
公开号:EP2507223A1
公开(公告)日:2012-10-10
US9949979B2
申请人:——
公开号:US9949979B2
公开(公告)日:2018-04-24
[EN] BENZPYRAZOLE DERIVATIVES AS INHIBITORS OF P13 KINASES<br/>[FR] DÉRIVÉS DE BENZPYRAZOLE COMME INHIBITEURS DES PI3 KINASES
申请人:GLAXO GROUP LTD
公开号:WO2011067365A1
公开(公告)日:2011-06-09
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.